000 | 01958 a2200553 4500 | ||
---|---|---|---|
005 | 20250515010639.0 | ||
264 | 0 | _c20060919 | |
008 | 200609s 0 0 eng d | ||
022 | _a0035-9203 | ||
024 | 7 |
_a10.1016/j.trstmh.2005.09.018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTinto, Halidou | |
245 | 0 | 0 |
_aIn-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. _h[electronic resource] |
260 |
_bTransactions of the Royal Society of Tropical Medicine and Hygiene _cJun 2006 |
||
300 |
_a509-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmodiaquine _xanalogs & derivatives |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimalarials _xpharmacology |
650 | 0 | 4 |
_aArtemisinins _xpharmacology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aChloroquine _xpharmacology |
650 | 0 | 4 | _aDrug Resistance, Multiple |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
650 | 0 | 4 |
_aQuinine _xpharmacology |
650 | 0 | 4 | _aRwanda |
650 | 0 | 4 |
_aSesquiterpenes _xpharmacology |
700 | 1 | _aRwagacondo, Claude | |
700 | 1 | _aKarema, Corinne | |
700 | 1 | _aMupfasoni, Denise | |
700 | 1 | _aVandoren, Waltruda | |
700 | 1 | _aRusanganwa, Emmanuel | |
700 | 1 | _aErhart, Annette | |
700 | 1 | _aVan Overmeir, Chantal | |
700 | 1 | _aVan Marck, Eric | |
700 | 1 | _aD'Alessandro, Umberto | |
773 | 0 |
_tTransactions of the Royal Society of Tropical Medicine and Hygiene _gvol. 100 _gno. 6 _gp. 509-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.trstmh.2005.09.018 _zAvailable from publisher's website |
999 |
_c15958854 _d15958854 |